Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Pandyanda Nanjappa Dechamma"'
Autor:
Ravindra, Jeshma, UG, Yathisha, Pandyanda Nanjappa, Dechamma, Kalladka, Krithika, Dhakal, Rasik, Chakraborty, Anirban, Chakraborty, Gunimala
Publikováno v:
In Biomedicine & Pharmacotherapy 31 December 2023 169
Autor:
Mohan, Masmarika, Gaonkar, Anjali Arun, Pandyanda Nanjappa, Dechamma, K, Krithika, Vittal, Rajeshwari, Chakraborty, Anirban, Chakraborty, Gunimala
Publikováno v:
In Chemosphere November 2023 341
Autor:
Marina Saldanha, Audrey Madonna D'Cruz, Anirban Chakraborty, Pandyanda Nanjappa Dechamma, Pushparaja Shetty, Sahana Maben
Publikováno v:
Asian Pacific Journal of Cancer Prevention. 22:3287-3291
Background Oral Squamous Cell Carcinoma (OSCC) is the most widely reported cancer worldwide. Liquid biopsy, a method that relies on identification of tumor-associated cells and/or cell free nucleic acids from body fluids is becoming increasingly popu
Autor:
Dhakal, Rasik, Kalladka, Krithika, Singha, Achinta, Pandyanda Nanjappa, Dechamma, Ravindra, Jeshma, Vittal, Rajeshwari, Sil, Samir Kumar, Chakraborty, Anirban, Chakraborty, Gunimala
Publikováno v:
PLoS ONE; 7/21/2023, Vol. 18 Issue 7, p1-11, 11p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Shenoy, Rathika D., Shetty, Vikram, Dheedene, Annelies, Menten, Björn, Pandyanda Nanjappa, Dechamma, Chakraborty, Gunimala, Sips, Patrick, de Paepe, Anne, Callewaert, Bert, Chakraborty, Anirban
Publikováno v:
Cleft Palate Craniofacial Journal; Nov2022, Vol. 59 Issue 11, p1346-1351, 6p
Autor:
Pandyanda Nanjappa Dechamma, Rajesh Venkataram, Anirban Chakraborty, Srividya Arjuna, Gunimala Chakraborty
Publikováno v:
Journal of Carcinogenesis
Journal of Carcinogenesis, Vol 19, Iss 1, Pp 3-3 (2020)
Journal of Carcinogenesis, Vol 19, Iss 1, Pp 3-3 (2020)
INTRODUCTION: Targeted therapy using specific inhibitors against tyrosine kinases (TKs) is a paradigm in non-small-cell lung cancer management. However, the success of TK inhibitor (TKI) therapy depends on certain activating or acquired mutations, wh
Autor:
Shenoy RD; Department of Pediatrics, KS Hegde Medical Academy, 231912Nitte (Deemed to be University), Mangaluru, India., Shetty V; Department of Maxillofacial Surgery, AB Shetty Memorial Institute of Dental Sciences, Nitte Meenakshi Institute of Craniofacial Surgery, 231912Nitte (Deemed to be University), Mangaluru, India., Dheedene A; Department of Biomolecular Medicine, Center for Medical Genetics, Ghent University Hospital, 26656Ghent University, Ghent, Belgium., Menten B; Department of Biomolecular Medicine, Center for Medical Genetics, Ghent University Hospital, 26656Ghent University, Ghent, Belgium., Pandyanda Nanjappa D; Division of Molecular Genetics and Cancer, Nitte University Centre for Science Education and Research (NUCSER), 231912Nitte (Deemed to be University), Mangaluru, India., Chakraborty G; Division of Molecular Genetics and Cancer, Nitte University Centre for Science Education and Research (NUCSER), 231912Nitte (Deemed to be University), Mangaluru, India., Sips P; Department of Biomolecular Medicine, 26656Ghent University, Ghent, Belgium., de Paepe A; Department of Biomolecular Medicine, Center for Medical Genetics, Ghent University Hospital, 26656Ghent University, Ghent, Belgium., Callewaert B; Department of Biomolecular Medicine, Center for Medical Genetics, Ghent University Hospital, 26656Ghent University, Ghent, Belgium., Chakraborty A; Division of Molecular Genetics and Cancer, Nitte University Centre for Science Education and Research (NUCSER), 231912Nitte (Deemed to be University), Mangaluru, India.
Publikováno v:
The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association [Cleft Palate Craniofac J] 2022 Nov; Vol. 59 (11), pp. 1346-1351. Date of Electronic Publication: 2021 Oct 29.